Connection

John Wrangle to Disease-Free Survival

Back to Details
This is a "connection" page, showing publications John Wrangle has written about Disease-Free Survival.
John Wrangle
Connection Strength
0.112
Disease-Free Survival
  1. First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer. N Engl J Med. 2017 06 22; 376(25):2415-2426.
    View in: PubMed
    Score: 0.034
  2. Neutrophil-to-lymphocyte ratio and overall survival in all sites of head and neck squamous cell carcinoma. Head Neck. 2016 04; 38 Suppl 1:E1068-74.
    View in: PubMed
    Score: 0.031
  3. Human immunodeficiency virus infection as a prognostic factor in surgical patients with non-small cell lung cancer. Ann Thorac Surg. 2012 Feb; 93(2):405-12.
    View in: PubMed
    Score: 0.024
  4. Combination epigenetic therapy has efficacy in patients with refractory advanced non-small cell lung cancer. Cancer Discov. 2011 Dec; 1(7):598-607.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.